Basics Kymera Therapeutics, Inc. IPO Date: August 21, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.83B Activated in VL: True Average Daily Range Avg Daily Range: $1.21 | 3.27% Avg Daily Range (30 D): $1.01 | 3.29% Avg Daily Range (90 D): $1.03 | 3.31% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .54M Avg Daily Volume (90 D): .56M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 51 Institutional Trades Total Inst.Trades: 2,029 Avg Inst. Trade: $2.38M Avg Inst. Trade (30 D): $2.19M Avg Inst. Trade (90 D): $2.19M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.09M Avg Closing Trade (30 D): $2.61M Avg Closing Trade (90 D): $2.72M Avg Closing Volume: 90.5K         News Jun 2, 2025 @ 11:00 AM Kymera Therapeutics Announces Positive First-in-Hu... Source: Kymera Therapeutics May 29, 2025 @ 11:00 AM Kymera Therapeutics to Participate in Upcoming Jun... Source: N/A May 9, 2025 @ 11:00 AM Kymera Therapeutics Announces First Quarter 2025 F... Source: Kymera Therapeutics May 7, 2025 @ 11:00 AM Kymera Therapeutics to Participate in Fireside Cha... Source: N/A Apr 25, 2025 @ 10:03 PM Why Kymera Therapeutics Stock Crushed it This Week... Source: Eric Volkman Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.11 $-.82 $-.89 Diluted EPS $-3.11 $-.82 $-.89 Revenue $ 58.89M $ 22.1M $ 7.39M Gross Profit $ M $ M $ Net Income / Loss $ -240.88M $ -65.58M $ -70.75M Operating Income / Loss $ -278.23M $ -74.43M $ -80.76M Cost of Revenue $ 58.89M $ 22.1M $ Net Cash Flow $ -3.56M $ -30.28M $ 9.55M PE Ratio